London based health tech startup secures $11m investment

A UK and US health tech startup has announced that it has secured $11m of funding.

Quit Genius, which has its UK headquarters in London, has received the investment from a Series A funding round led by Octopus Ventures.

Hubert Burda Media’s international growth capital arm BurdaPrincipal Investments joined the round along with Y Combinator, Startup Health, and Triple Point Ventures.

The company uses cognitive behavioural therapy aims to aid users in quitting smoking and vaping tobacco products.

Quit Genius is expected to use the funding to expand into other types of addiction, including alcohol and opioid addiction.

Amelia Townsend, principal at BurdaPrincipal Investments, commented: “At BPI we are working in-depth into the health tech space.

“We are delighted to join the Quit Genius team and our fellow investors and are looking forward to being part of the journey!”